Results 41 to 50 of about 3,973,140 (195)
Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice
Psychedelic Harm Reduction and Integration (PHRI) is a transtheoretical and transdiagnostic clinical approach to working with patients who are using or considering using psychedelics in any context.
Ingmar Gorman +11 more
doaj +1 more source
Learning to Let Go: A Cognitive-Behavioral Model of How Psychedelic Therapy Promotes Acceptance
The efficacy of psychedelic-assisted therapies for mental disorders has been attributed to the lasting change from experiential avoidance to acceptance that these treatments appear to facilitate.
Max Wolff +8 more
doaj +1 more source
As investigations into the efficacy of psychedelic-assisted psychotherapy to treat depression continue, there is a need to study the possible mechanisms of action that may contribute to the treatment’s antidepressant effects.
Lauren Johansen +4 more
doaj +1 more source
Psychedelic-assisted therapy research for depression and PTSD has been fast tracked in the United States with the Food and Drugs Administration (FDA) granting breakthrough designations for MDMA (post-traumatic stress disorder) and psilocybin (major ...
Henry J. Whitfield (11803265)
core +1 more source
The Swiss Federal Act on Narcotics allows for the restricted medical use of scheduled psychotropic drugs in cases of resistance to standard treatment, and preliminary evidence of efficacy of the scheduled drug for the particular condition.
Peter Oehen, Peter Gasser
doaj +1 more source
Corrigendum to "Psychedelic Assisted Therapy as a Complex Intervention: Implications for clinical trial design". [PDF]
europepmc +2 more sources
Background Psychedelic-assisted therapy (PaT)—psychotherapy combined with medicines, such as psilocybin, 3,4-methylenedioxymethamphetamine (MDMA) or ketamine within a psychedelic dose range—is rapidly expanding in community-based settings.
Vivian W L Tsang +5 more
doaj +1 more source
Psychedelic-assisted therapy research for depression and PTSD has been fast tracked in the United States with the Food and Drugs Administration (FDA) granting breakthrough designations for MDMA (post-traumatic stress disorder) and psilocybin (major ...
Henry J. Whitfield (11803265)
core +1 more source
This paper aims to identify the effects of ayahuasca on humans and more specifically how this substance defines changes within psychological and behavioral patterns, including experience of emotions, decision-making processes, and life changes. The demand for the new-wave of antidepressants based on psychedelic substances places emphasis on the study ...
Maria Laura Mele, Stefano Federici
openaire +2 more sources
Functional neurological disorders (FNDs), which are sometimes also referred to as psychogenic neurological disorders or conversion disorder, are common disabling neuropsychiatric disorders with limited treatment options. FNDs can present with sensory and/
Benjamin Stewart +12 more
doaj +1 more source

